Releases
Press release
PhAST Corp. Receives FDA Clearance for Rapid Antimicrobial Susceptibility Testing Directly From Positive Blood Cultures
The PhAST BC GN Panel delivers phenotypic susceptibility results in approximately 100 minutes for Enterobacterales and Acinetobacter spp. and 140 minutes for Pseudomonas aeruginosa, directly from positive blood cultures, across 15 antimicrobials
Regulatory
PhAST receives FDA 510(k) clearance for the PhAST BC GN Panel
The panel provides phenotypic antimicrobial susceptibility results for Gram-negative pathogens for 15 antimicrobials directly from positive blood cultures.